Rosuvastatin effect on atherosclerotic plaque metabolism: A subclinical atherosclerosis imaging study with (18)F-NaF PET-CT

CONCLUSION: In a single-centre non-randomized clinical trial of high CV risk individuals with subclinical atherosclerosis, the maximum atherosclerotic plaque 18F-NaF uptake was significantly reduced after six months of high-intensity statin.PMID:38480058 | DOI:10.1016/j.atherosclerosis.2024.117481

Source: Atherosclerosis - March 13, 2024 Category: Cardiology Authors: Manuel Oliveira-Santos Jo ão Borges-Rosa Rodolfo Silva Lu ís Paixão Cl áudio Espírito Santo Antero Abrunhosa Miguel Castelo-Branco Piotr J Slomka Lino Gon çalves Maria Jo ão Ferreira Source Type: research